(Q34817460)

4 August 2017

GATA3 cooperates with PARP1 to regulate CCND1 transcription through modulating histone H1 incorporation (English)

1 reference

4 August 2017

L Shan

1

1 reference

4 August 2017

X Li

2

1 reference

4 August 2017

L Liu

3

1 reference

4 August 2017

X Ding

4

1 reference

4 August 2017

Q Wang

5

1 reference

4 August 2017

Y Zheng

6

1 reference

4 August 2017

Y Duan

7

1 reference

4 August 2017

C Xuan

8

1 reference

4 August 2017

Y Wang

9

1 reference

4 August 2017

F Yang

10

1 reference

4 August 2017

Y Shang

11

1 reference

4 August 2017

L Shi

12

1 reference

4 August 2017

language of work or name

English

0 references

publication date

15 July 2013

1 reference

4 August 2017

1 reference

4 August 2017

33

1 reference

4 August 2017

24

1 reference

4 August 2017

3205-3216

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2013.270

4 August 2017

0 references

cites work

The GATA family (vertebrates and invertebrates).

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

GATA factors in human neuroblastoma: distinctive expression patterns in clinical subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Essential role of Gata transcription factors in sympathetic neuron development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Chronic melatonin treatment and the hypothalamo-pituitary-adrenal axis in the rat: attenuation of the secretory response to stress and effects on hypothalamic neuropeptide content and release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Mast cell lineage diversion of T lineage precursors by the essential T cell transcription factor GATA-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Transcription factor GATA-3 is required for development of the T-cell lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

GATA-3 and the regulation of the mammary luminal cell fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

GATA Transcription Factors and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

The significance of GATA3 expression in breast cancer: a 10-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Higher levels of GATA3 predict better survival in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

GATA-3 expression as a predictor of hormone response in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Meta-analysis of human cancer microarrays reveals GATA3 is integral to the estrogen receptor alpha pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Coactivator and corepressor complexes in nuclear receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Transcriptional regulation through noncoding RNAs and epigenetic modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Review: chromatin structural features and targets that regulate transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Physical and functional interaction between GATA-3 and Smad3 allows TGF-beta regulation of GATA target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Genome-wide analyses of transcription factor GATA3-mediated gene regulation in distinct T cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

NAD+-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

SIRT6 promotes DNA repair under stress by activating PARP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

PARP-1, a determinant of cell survival in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

PARP-1, PARP-2 and ATM in the DNA damage response: functional synergy in mouse development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

PARP-1 regulates chromatin structure and transcription through a KDM5B-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

PARP-1 attenuates Smad-mediated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Cyclin D1 in breast cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

PARP-1 inhibitors: a novel genetically specific agents for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Upregulation of Poly (ADP-Ribose) Polymerase-1 (PARP1) in Triple-Negative Breast Cancer and Other Primary Human Tumor Types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Differential gene regulation by the SRC family of coactivators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Reciprocal binding of PARP-1 and histone H1 at promoters specifies transcriptional outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

The activities of cyclin D1 that drive tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Modulation of transcription by PARP-1: consequences in carcinogenesis and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

DNA ligase III promotes alternative nonhomologous end-joining during chromosomal translocation formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

The DNA Damage Response: Making It Safe to Play with Knives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Transcription-induced DNA double strand breaks: both oncogenic force and potential therapeutic target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

ZIP: a novel transcription repressor, represses EGFR oncogene and suppresses breast carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Cyclin D1 protein expression and function in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

GATA factors induce mouse embryonic stem cell differentiation toward extraembryonic endoderm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

GATA-3 is expressed in association with estrogen receptor in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

Re-evaluating PARP1 inhibitor in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.270

31 March 2020

Identifiers

DOI

10.1038/ONC.2013.270

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference